Microbiome World Congress Americas 2017 will bring together leading pharma and biotechs, academic researcher, and their partners to discuss how to successfully commercialize microbiome-based diagnostics, therapeutics, adjunct therapies and direct-to-consumer services and products.
Our Mission:
-
To create a forum where the entire community can come together to learn, network and develop the partnerships necessary to develop microbiome-based diagnostics and therapies.
-
To provide a place where pharma and biotechs meet with the solution providers they need to develop diagnostics and therapies.
-
To give academic researchers insights into how to develop and commercialize their research.
-
To provide clinicians with key insights into this new area of medicine and what it means for them.
-
To be a showcase for the latest technology to enable research to be commercially developed.
-
To highlight investment opportunities in this fast-growing sector, and to be a place where early stage startups can pitch for investment.